Interestingly, USP52 is low expressed as a tumor suppressor gene in lung cancer, but overexpressed as an oncogene in breast cancer.[18, 21] However, its role in BLCA has not been characterized. Here, PAN2 is linked to bladder transitional cell carcinoma.